{"type": "variant", "id": "var_20210111_mthfr_c677t_001", "document_hash": "4fbadfd0cce97bc7c5891d1ddf19ce2c906b9df26174819c9100a3248f502622", "document_date": "2021-01-11", "category": "Blood", "gene": "MTHFR", "variant": "C677T", "rs_id": null, "hgvs_c": "c.665C>T", "hgvs_p": "p.Ala222Val", "classification": "Normal", "inheritance": "Homozygous normal (CC)", "genotype": "CC", "condition": "Folate metabolism / Methylation", "clinical_significance": "Absence of variant - normal enzyme activity", "population_frequency": "45% - 50.8% (Brazilian female population)", "lab": "Laboratório Oswaldo Cruz (DASA)", "physician": "Dr. Gustavo Aguiar Campana", "crm": "112.181", "method": "PCR em Tempo Real - Sistema FRET", "source_file": "/Users/tony/isaacstory/isaacstory2/Exams/Blood/20210111_DraSimone_Sangue_2.pdf", "markdown_file": "/Users/tony/isaacstory/isaacstory2/markdown/Exams/Blood/20210111_DraSimone_Sangue_2.md"}
{"type": "variant", "id": "var_20210111_mthfr_a1298c_001", "document_hash": "4fbadfd0cce97bc7c5891d1ddf19ce2c906b9df26174819c9100a3248f502622", "document_date": "2021-01-11", "category": "Blood", "gene": "MTHFR", "variant": "A1298C", "rs_id": null, "hgvs_c": "c.1286A>C", "hgvs_p": "p.Glu429Ala", "classification": "Abnormal", "inheritance": "Heterozygous (AC)", "genotype": "AC", "condition": "Folate metabolism / Methylation", "clinical_significance": "Presence of variant in one chromosome - may cause reduced enzyme activity", "population_frequency": "36% (Brazilian female population)", "lab": "Laboratório Oswaldo Cruz (DASA)", "physician": "Dr. Gustavo Aguiar Campana", "crm": "112.181", "method": "PCR em Tempo Real - Sistema FRET", "source_file": "/Users/tony/isaacstory/isaacstory2/Exams/Blood/20210111_DraSimone_Sangue_2.pdf", "markdown_file": "/Users/tony/isaacstory/isaacstory2/markdown/Exams/Blood/20210111_DraSimone_Sangue_2.md"}
{"type": "variant", "id": "var_20210111_3q26_001", "document_hash": "75a323c2c39dd49ac421124f15bb8a6c4de4cd462302ee0927f25d86b6a82e48", "document_date": "2021-01-11", "category": "Genetic", "gene": "3q26.31q26.32", "variant": "arr[GRCh38] 3q26.31q26.32(175364178_176001139)x1", "variant_type": "Deletion", "size": "637 kb", "coordinates": "chr3:175364178-176001139 (GRCh38)", "classification": "Likely Benign", "classification_original": "Provavelmente Benigna", "inheritance": null, "condition": null, "clinical_significance": "No evidence that this deletion causes clinical phenotype. Similar deletions found in rare general population individuals.", "genes_affected": ["NAALADL2", "MIR4789", "RNU6-1233P", "RNU4-91P", "UBE2V1P2", "RNU6-1317P", "NAALADL2-AS1", "ACTG1P23"], "omim_diseases": null, "sex_chromosomes": "XY", "platform": "Illumina Infinium CytoSNP 850k", "genome_version": "GRCh38", "lab": "GeneOne / DASA (Laboratório Oswaldo Cruz)", "physician": "DraSimone", "released_by": "Carla Rosenberg CRBIO-SP 5005942", "release_date": "2021-01-27", "source_file": "/Users/tony/isaacstory/isaacstory2/Exams/Genetic/20210111_DraSimone_Microarray.pdf", "markdown_file": "/Users/tony/isaacstory/isaacstory2/markdown/Exams/Genetic/20210111_DraSimone_Microarray.md"}
{"type": "variant", "id": "var_20240123_galt_001", "document_hash": "5f924c9cfff2731c6571b78a0c7a83816dcedf87c668578aa219a41bc8d78e10", "document_date": "2024-01-23", "category": "Genetic", "gene": "GALT", "variant": "NM_000155:c.C404T (p.S135L)", "location": "Chr9:34647858", "classification": "Pathogenic", "inheritance": "Heterozygous", "condition": "Galactosemia (OMIM: 230400)", "inheritance_pattern": "Autosomal Recessive", "clinical_significance": "Achado isolado em heterozigose - não suficiente para desenvolvimento da síndrome. Gene codifica Galactose-1-fosfato uridil transferase. Fenótipo associado: catarata, cirrose, vômito, diarreia, atraso de desenvolvimento, anemia hemolítica.", "dbsnp": "rs111033690", "population_frequency": "ABraOM: 0.0004%, GnomAD: 0.0009%", "lab": "Tismoo", "provider": "BioRaras", "protocol": "JST2203", "source_file": "/Users/tony/isaacstory/isaacstory2/Exams/Genetic/20240123_Bioraras_Exoma.pdf", "markdown_file": "/Users/tony/isaacstory/isaacstory2/markdown/Exams/Genetic/20240123_Bioraras_Exoma.md"}
{"type": "variant", "id": "var_20240123_med13_001", "document_hash": "5f924c9cfff2731c6571b78a0c7a83816dcedf87c668578aa219a41bc8d78e10", "document_date": "2024-01-23", "category": "Genetic", "gene": "MED13", "variant": "NM_005121:c.A866T (p.D289V)", "location": "Chr17:62031587", "classification": "VUS", "acmg_criteria": "PM2, PP3, BP1", "inheritance": "Heterozygous", "condition": "Transtorno de desenvolvimento intelectual (OMIM: 618009)", "inheritance_pattern": "Autosomal Dominant", "clinical_significance": "Variante de novo. Fenótipo AD associado: Atraso global no desenvolvimento, desenvolvimento intelectual levemente prejudicado, atraso na fala expressiva, TEA, TDAH, características dismórficas variáveis.", "dbsnp": "rs925249026", "sfari_score": "1 (associação comprovada)", "in_silico_predictions": "Potencialmente patogênica (8), incerto (12), neutra (0)", "conservation_score": "PhastCons100way: 1.000 (alto)", "lab": "Tismoo", "provider": "BioRaras", "protocol": "JST2203", "source_file": "/Users/tony/isaacstory/isaacstory2/Exams/Genetic/20240123_Bioraras_Exoma.pdf", "markdown_file": "/Users/tony/isaacstory/isaacstory2/markdown/Exams/Genetic/20240123_Bioraras_Exoma.md"}
{"type": "variant", "id": "var_20240123_ass1_001", "document_hash": "5f924c9cfff2731c6571b78a0c7a83816dcedf87c668578aa219a41bc8d78e10", "document_date": "2024-01-23", "category": "Genetic", "gene": "ASS1", "variant": "NM_054012:c.G299A (p.R100H)", "location": "Chr9:130458525", "classification": "VUS", "acmg_criteria": "PM1, PM2, PM5, PP5, BP4", "inheritance": "Heterozygous", "condition": "Citrulinemia (OMIM: 215700)", "inheritance_pattern": "Autosomal Recessive", "clinical_significance": "Região hotspot para variantes patogênicas. Achado isolado em heterozigose - não suficiente para desenvolvimento da síndrome AR. Fenótipo: vômitos, hepatomegalia, letargia, convulsão, atraso de desenvolvimento, irritabilidade, episódios de intoxicação por amônia.", "dbsnp": "rs138279074", "population_frequency": "ABraOM: 0.001%, GnomAD: 0.00018%", "in_silico_predictions": "Potencialmente patogênica (8), incerto (13), neutra (3)", "conservation_score": "PhastCons100way: 1.000 (alto)", "lab": "Tismoo", "provider": "BioRaras", "protocol": "JST2203", "source_file": "/Users/tony/isaacstory/isaacstory2/Exams/Genetic/20240123_Bioraras_Exoma.pdf", "markdown_file": "/Users/tony/isaacstory/isaacstory2/markdown/Exams/Genetic/20240123_Bioraras_Exoma.md"}
{"type": "variant", "id": "var_20240123_tat_001", "document_hash": "5f924c9cfff2731c6571b78a0c7a83816dcedf87c668578aa219a41bc8d78e10", "document_date": "2024-01-23", "category": "Genetic", "gene": "TAT", "variant": "NM_000353:c.G998A (p.R333H)", "location": "Chr16:71570312", "classification": "VUS", "acmg_criteria": "PM2, BP4", "inheritance": "Heterozygous", "condition": "Tirosinemia, tipo II (OMIM: 276600)", "inheritance_pattern": "Autosomal Recessive", "clinical_significance": "Achado isolado em heterozigose - não suficiente para desenvolvimento da síndrome AR. Codifica tirosina aminotransferase mitocondrial. Fenótipo: atraso de desenvolvimento, queratoses dolorosas nos dedos, palmas e plantas.", "dbsnp": "rs771408463", "population_frequency": "ALFA: 0.000028%, GnomAD: 0.000024%", "in_silico_predictions": "Potencialmente patogênica (1), incerto (8), neutra (15)", "conservation_score": "PhastCons100way: 0.901 (alto)", "lab": "Tismoo", "provider": "BioRaras", "protocol": "JST2203", "source_file": "/Users/tony/isaacstory/isaacstory2/Exams/Genetic/20240123_Bioraras_Exoma.pdf", "markdown_file": "/Users/tony/isaacstory/isaacstory2/markdown/Exams/Genetic/20240123_Bioraras_Exoma.md"}
{"type": "variant", "id": "var_20240123_fhl1_001", "document_hash": "5f924c9cfff2731c6571b78a0c7a83816dcedf87c668578aa219a41bc8d78e10", "document_date": "2024-01-23", "category": "Genetic", "gene": "FHL1", "variant": "NM_001159699:c.A665G (p.Q222R)", "location": "ChrX:136208570", "classification": "VUS", "acmg_criteria": "PM2, BP4, PM1", "inheritance": "Hemizygous", "condition": "Distrofia muscular de Emery-Dreifuss tipo 6 (OMIM: 300696); Miopatia corporal redutora tipo 1A/1B (OMIM: 300717/300718); Miopatia escapuloperoneal (OMIM: 300695)", "inheritance_pattern": "X-linked", "clinical_significance": "Região hotspot para variantes patogênicas. Proteína da família LIM com domínios de dedo de zinco. Fenótipos associados incluem arritmias, defeitos de condução cardíaca, fraqueza muscular, contraturas articulares, cardiomiopatia, insuficiência respiratória.", "dbsnp": "rs915687031", "population_frequency": "ABraOM: 0.001%, TOMMO: 0.00008%", "in_silico_predictions": "Incerto (12), neutra (7)", "conservation_score": "PhastCons100way: 1.000 (alto)", "lab": "Tismoo", "provider": "BioRaras", "protocol": "JST2203", "source_file": "/Users/tony/isaacstory/isaacstory2/Exams/Genetic/20240123_Bioraras_Exoma.pdf", "markdown_file": "/Users/tony/isaacstory/isaacstory2/markdown/Exams/Genetic/20240123_Bioraras_Exoma.md"}
{"type": "variant", "id": "var_20240123_dlgap1_001", "document_hash": "5f924c9cfff2731c6571b78a0c7a83816dcedf87c668578aa219a41bc8d78e10", "document_date": "2024-01-23", "category": "Genetic", "gene": "DLGAP1", "variant": "NM_001242761:c.A850G (p.T284A)", "location": "Chr18:3879219", "classification": "VUS", "acmg_criteria": "PM2, PP2, BP4", "inheritance": "Heterozygous", "condition": "Susceptibilidade ao TEA", "inheritance_pattern": null, "clinical_significance": "Gene de susceptibilidade ao TEA com SFARI Score 2 (forte candidato).", "dbsnp": "rs200178260", "sfari_score": "2 (forte candidato)", "population_frequency": "ExAC: 0.000009%", "in_silico_predictions": "Potencialmente patogênica (7), incerto (10), neutra (5)", "conservation_score": "PhastCons100way: 0.901 (alto)", "lab": "Tismoo", "provider": "BioRaras", "protocol": "JST2203", "source_file": "/Users/tony/isaacstory/isaacstory2/Exams/Genetic/20240123_Bioraras_Exoma.pdf", "markdown_file": "/Users/tony/isaacstory/isaacstory2/markdown/Exams/Genetic/20240123_Bioraras_Exoma.md"}
{"type": "variant", "id": "var_20250502_med13_001", "document_hash": "b4830168af62f319f4c996db092c067c38375d330285b9049bd78bf814d18684", "document_date": "2025-05-02", "category": "Genetic", "gene": "MED13", "variant": "c.866A>T (p.Asp289Val)", "transcript": "NM_005121.3", "dbsnp": "rs925249026", "classification": "Uncertain Significance", "inheritance": "Heterozygous", "inheritance_pattern": "Autosomal dominant", "family_inheritance": "Paternal (heterozygous in father, not in mother)", "condition": "Intellectual developmental disorder 61", "gnomad_frequency": "0.0022%", "revel_score": 0.903, "evidence": "PP3_Moderate, PM2_Supporting", "clinical_significance": "Pathogenic variants in MED13 are associated with autosomal dominant neurodevelopmental disorders. Based on current evidence, this variant is classified as uncertain for autosomal dominant intellectual developmental disorder 61.", "lab": "Variantyx Inc.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.md"}
{"type": "variant", "id": "var_20250502_galt_001", "document_hash": "b4830168af62f319f4c996db092c067c38375d330285b9049bd78bf814d18684", "document_date": "2025-05-02", "category": "Genetic", "gene": "GALT", "variant": "c.404C>T (p.Ser135Leu)", "transcript": "NM_000155.4", "dbsnp": "rs111033690", "classification": "Supplementary Finding", "inheritance": "Heterozygous", "family_inheritance": "Maternal (not in father, heterozygous in mother)", "condition": null, "clinical_significance": "Previously reported supplementary finding", "lab": "Variantyx Inc.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.md"}
{"type": "variant", "id": "var_20250502_ass1_001", "document_hash": "b4830168af62f319f4c996db092c067c38375d330285b9049bd78bf814d18684", "document_date": "2025-05-02", "category": "Genetic", "gene": "ASS1", "variant": "c.299G>A (p.Arg100His)", "transcript": "NM_054012.4", "dbsnp": "rs138279074", "classification": "Supplementary Finding", "inheritance": "Heterozygous", "family_inheritance": "Maternal (not in father, heterozygous in mother)", "condition": null, "clinical_significance": "Previously reported supplementary finding", "lab": "Variantyx Inc.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.md"}
{"type": "variant", "id": "var_20250502_tat_001", "document_hash": "b4830168af62f319f4c996db092c067c38375d330285b9049bd78bf814d18684", "document_date": "2025-05-02", "category": "Genetic", "gene": "TAT", "variant": "c.998G>A (p.Arg333His)", "transcript": "NM_000353.3", "dbsnp": "rs771408463", "classification": "Supplementary Finding", "inheritance": "Heterozygous", "family_inheritance": "Maternal (not in father, heterozygous in mother)", "condition": null, "clinical_significance": "Previously reported supplementary finding", "lab": "Variantyx Inc.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.md"}
{"type": "variant", "id": "var_20250502_fhl1_001", "document_hash": "b4830168af62f319f4c996db092c067c38375d330285b9049bd78bf814d18684", "document_date": "2025-05-02", "category": "Genetic", "gene": "FHL1", "variant": "c.617A>G (p.Gln206Arg)", "transcript": "NM_001159702.3", "dbsnp": "rs915687031", "classification": "Supplementary Finding", "inheritance": "Hemizygous", "family_inheritance": "Maternal (not in father, heterozygous in mother)", "condition": null, "clinical_significance": "Previously reported supplementary finding", "lab": "Variantyx Inc.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.md"}
{"type": "variant", "id": "var_20250502_3q26_deletion_001", "document_hash": "b4830168af62f319f4c996db092c067c38375d330285b9049bd78bf814d18684", "document_date": "2025-05-02", "category": "Genetic", "gene": "3q26.31q26.32", "variant": "668.17 kb deletion", "variant_type": "Structural Variant", "coordinates": "chr3:175,361,472-176,029,643", "reference_genome": "GRCh38", "iscn": "seq[GRCh38] del(3)(q26.31q26.32)pat", "classification": "Supplementary Finding", "inheritance": "Heterozygous", "family_inheritance": "Paternal (heterozygous in father, not in mother)", "condition": null, "clinical_significance": "Previously reported structural variant", "lab": "Variantyx Inc.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250502_Variantyx_AvaliacaoGenetica.md"}
{"type": "variant", "id": "var_20250609_slc22a5_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "SLC22A5", "variant": "c.254_264dupGGCTCGCCACC", "protein_change": "p.Ile89GlyfsTer45", "location": "chr5:132,370,222", "variant_type": "Frameshift", "classification": "Pathogenic", "inheritance": "Heterozygous", "origin": "De novo (paternal gonadal mosaicism)", "allele_fraction_proband": 0.52, "allele_fraction_father": 0.21, "allele_fraction_mother": 0, "population_frequency": 2.28e-05, "clinvar": "Pathogenic x11", "condition": "Primary systemic carnitine deficiency (OMIM: 212140)", "clinical_significance": "Good candidate - Carnitine deficiency. Loss of function variant in carnitine transporter gene. Heterozygous carriers may have mild carnitine deficiency.", "gene_function": "Sodium-dependent high-affinity carnitine transporter. Involved in active cellular uptake of carnitine.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20250609_trap1_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "TRAP1", "variant": "c.1163G>A", "protein_change": "p.Arg388Gln", "location": "chr16:3,672,702", "variant_type": "Missense (probable splice-site variant)", "classification": "VUS", "inheritance": "Heterozygous", "origin": "Paternal", "allele_fraction_proband": 0.51, "allele_fraction_father": 0.57, "allele_fraction_mother": 0, "population_frequency": 0.0003391, "revel_score": 0.266, "spliceada_score": 0.89730772915607, "condition": "Developmental disorder, cyclic vomiting syndrome, late-onset Parkinson disease, congenital kidney/urinary tract anomalies", "clinical_significance": "Very good candidate - Mitochondrial chaperone. Highly likely to alter protein function by affecting splice site. Gene associated with autism.", "gene_function": "Mitochondrial chaperone expressing ATPase activity. Involved in maintaining mitochondrial function and polarization through complex I stabilization.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20250609_scn9a_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "SCN9A", "variant": "c.2190G>C", "protein_change": "p.Trp730Cys", "location": "chr2:166,280,510", "variant_type": "Missense", "classification": "Likely Benign", "inheritance": "Heterozygous", "origin": "Paternal", "allele_fraction_proband": 0.54, "allele_fraction_father": 0.47, "allele_fraction_mother": 0, "population_frequency": 0.0012346, "revel_score": 0.857, "clinvar": "Likely benign x7, Benign x2", "condition": "Primary erythromelalgia, Paroxysmal extreme pain disorder, Small fiber neuropathy, Congenital insensitivity to pain", "clinical_significance": "Good candidate - Behavioral crises/pain. Likely to alter protein function (10/10 algorithms). Risk factor for behavioral crises associated with nociceptive signals like pain, nausea, heat.", "gene_function": "Voltage-dependent sodium channel Nav1.7. Transmits electrical signals in nociceptors (peripheral nerve cells that transmit pain signals).", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20250609_med13_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "MED13", "variant": "c.866A>T", "protein_change": "p.Asp289Val", "location": "chr17:62,031,587", "variant_type": "Missense", "classification": "VUS", "inheritance": "Heterozygous", "origin": "Paternal", "allele_fraction_proband": 0.52, "allele_fraction_father": 0.37, "allele_fraction_mother": 0, "population_frequency": 1.4e-06, "revel_score": 0.903, "acmg_criteria": "PP3_Moderate, PM2_Supporting", "condition": "Intellectual developmental disorder 61, autosomal dominant (MRD61) - OMIM: 618009", "clinical_significance": "Good candidate - Neurodevelopment. Likely to alter protein function (8/10 algorithms). MRD61 phenotypes include global developmental delay, mildly impaired intellectual development, expressive speech delay, behavioral abnormalities including ASD and ADHD.", "gene_function": "Component of Mediator complex, a coactivator involved in regulated transcription of nearly all RNA polymerase II-dependent genes.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20250609_naaladl2_cnv_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "NAALADL2", "variant": "3q26.31q26.32x1(175,361,471-176,029,643)", "variant_type": "CNV Deletion", "size": "668.17 kbp", "classification": "CNV", "inheritance": "Heterozygous", "origin": "Paternal", "population_frequency": 8.04e-05, "genes_affected": "NAALADL2 (54.36% of CDS), MIR4789, RNU6-1233P, RNU4-39P, UBE2V1P2, RNU6-1317P, NAALADL2-AS1, ACTGP23", "condition": "Craniofacial anomalies and learning difficulties, Developmental delay, SFARI Category 2 for autism", "clinical_significance": "Very good candidate - Neurodevelopment. Loss of function variant for NAALADL2.", "gene_function": "May be catalytically inactive. Similar to N-acetylated alpha-linked acidic dipeptidase.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20250609_mttt_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "MT-TT", "variant": "m.15929AG>GA", "location": "chrM:15,929", "variant_type": "Dinucleotide missense (ncRNA)", "classification": "VUS", "inheritance": "Homoplasmic", "origin": "Maternal", "heteroplasmy": "99% (m.15929A>G), 99% (m.15930G>A)", "population_frequency_m15929ag": 0.0010809, "population_frequency_m15930ga": 0.0087579, "clinvar": "MELAS syndrome", "condition": "Various predominantly neuromuscular conditions associated with mitochondrial disease", "clinical_significance": "Good candidate - Mitochondrial tRNA. Highly likely to alter protein function. Both variants commonly found in mtDNA haplogroup A.", "gene_function": "tRNA in mitochondrial protein translation.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20250609_mtnd1_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "MT-ND1", "variant": "m.3397A>G", "protein_change": "p.Met31Val", "location": "chrM:3,397", "variant_type": "Missense", "classification": "VUS", "inheritance": "Homoplasmic", "origin": "Maternal", "heteroplasmy": "100%", "population_frequency": 0.001524, "clinvar_parkinson": "Pathogenic (OMIM: 168500)", "clinvar_leigh": "Benign (OMIM: 256000)", "clinvar_alzheimer": "Pathogenic", "condition": "Late-onset Parkinson disease, Leigh syndrome, Alzheimer disease", "clinical_significance": "Good candidate - Complex I. Likely to alter protein function.", "gene_function": "Subunit of respiratory chain complex I, part of oxidative phosphorylation complex.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20250609_cacna1a_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "CACNA1A", "variant": "c.6949_6975delCAGCAGCAGCAGCAGCAGCAGCAGCAG", "protein_change": "p.Gln2317_Gln2325del", "location": "chr19:13,207,858", "variant_type": "Non-frameshift deletion (CAG repeat)", "cag_repeats": "4/11", "classification": "VUS", "inheritance": "Autosomal Dominant", "population_frequency": 0.0071233, "condition": "Familial hemiplegic migraine, Episodic ataxia type 2, Spinocerebellar ataxia type 6, Epileptic and developmental encephalopathy", "clinical_significance": "Possible candidate - Calcium channel. Deletion of 27 nucleotides in trinucleotide repeat resulting in loss of 9 glutamate amino acids.", "gene_function": "Neuronal calcium transporter.", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20250609_galt_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "GALT", "variant": "c.404C>T", "protein_change": "p.Ser135Leu", "transcript": "NM_000155.4", "classification": "Supplemental finding (previously reported pathogenic)", "inheritance": "Heterozygous", "origin": "Maternal", "dbsnp": "rs111033690", "condition": "Galactosemia", "clinical_significance": "Supplemental finding - Galactosemia carrier", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20250609_ass1_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "ASS1", "variant": "c.299G>A", "protein_change": "p.Arg100His", "transcript": "NM_054012.4", "classification": "VUS (supplemental)", "inheritance": "Heterozygous", "origin": "Maternal", "dbsnp": "rs138279074", "clinical_significance": "Supplemental finding - previously reported", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20250609_tat_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "TAT", "variant": "c.998G>A", "protein_change": "p.Arg333His", "transcript": "NM_000353.3", "classification": "VUS (supplemental)", "inheritance": "Heterozygous", "origin": "Maternal", "dbsnp": "rs771408463", "clinical_significance": "Supplemental finding - previously reported", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20250609_fhl1_001", "document_hash": "5cc7728a346af301775cc1cbcd4335edaf359c865cac4e6e7331beb8d3541b36", "document_date": "2025-06-09", "category": "Genetic", "gene": "FHL1", "variant": "c.617A>G", "protein_change": "p.Gln206Arg", "transcript": "NM_001159702.3", "classification": "VUS (supplemental)", "inheritance": "Hemizygous", "origin": "Maternal", "dbsnp": "rs915687031", "clinical_significance": "Supplemental finding - previously reported", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20250609_DrBoles_DrRogerio_RelatorioGenetico.md"}
{"type": "variant", "id": "var_20230707_med13_001", "document_hash": "7921f8ce034c014af7aceaed8c1f03a56cf039c412995f93138f245d7405a4d1", "document_date": "2023-07-07", "category": "Genetic", "gene": "MED13", "variant": "c.A866T (p.D289V)", "rsid": null, "isoform": "NM_005121", "chromosome_location": "17:62031587", "genome_build": "hg38", "classification": "VUS", "inheritance": "Heterozygous", "condition": "Transtorno do Espectro do Autismo (TEA) / Neurodevelopmental disorders", "clinical_significance": "Variante de significado clínico desconhecido. Gene MED13 é extremamente intolerante a alterações estruturais que causam perda de função e está associado a transtornos do neurodesenvolvimento. Variante não registrada em bancos de dados genômicos internacionais.", "amino_acid_change": "p.D289V", "nucleotide_change": "c.A866T", "lab": "TISMOO BIOTECH LABORATÓRIO LTDA", "physician": "Dr. Rogério Rodrigues Rita", "physician_crm": "CRM-SC 4.538", "test_type": "Exoma Completo", "sample_type": "Saliva (swab bucal)", "sample_date": "2023-04-18", "report_date": "2023-07-07", "recommendations": ["Correlacionar os achados genéticos com os dados clínicos", "Consultar serviço de aconselhamento genético, se necessário", "Reanalisar os dados do sequenciamento genético após 1 a 3 anos (conforme ACMG)", "Investigação nos progenitores para verificar possibilidade de mutação de novo"], "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20230418_Exoma.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20230418_Exoma.md"}
{"type": "variant", "id": "var_20240907_cyp2b6_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "CYP2B6", "variant": "*1/*1", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Normal Metabolizer", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_cyp2c19_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "CYP2C19", "variant": "*1/*17", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Rapid Metabolizer - may affect efficacy of SSRIs (citalopram, escitalopram), clobazam, diazepam, PPIs, voriconazole, clopidogrel", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_cyp2c9_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "CYP2C9", "variant": "*1/*1", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Normal Metabolizer", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_cyp2d6_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "CYP2D6", "variant": "*1/*4", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Intermediate Metabolizer - may alter systemic concentrations of tricyclic antidepressants, SSRIs, antipsychotics, codeine, tramadol, beta-blockers, tamoxifen", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_cyp3a5_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "CYP3A5", "variant": "*3/*3", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Poor Metabolizer - affects tacrolimus metabolism", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_cyp4f2_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "CYP4F2", "variant": "*1/*1", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Indeterminate", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_dpyd_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "DPYD", "variant": "c.85T>C (*9A)/c.1896T>C", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Normal Metabolizer - normal processing of fluoropyrimidines (capecitabine, fluorouracil)", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_nat2_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "NAT2", "variant": "*4/*5", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Indeterminate - follow up with additional risk assessment for amifampridine", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_nudt15_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "NUDT15", "variant": "*1/*1", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Normal Metabolizer - normal processing of thiopurines (mercaptopurine, thioguanine, azathioprine)", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_slco1b1_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "SLCO1B1", "variant": "*1/*14", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug transport", "clinical_significance": "Normal Function - normal statin transport (simvastatin, rosuvastatin)", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_tpmt_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "TPMT", "variant": "*1/*1", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Normal Metabolizer - normal processing of thiopurines (mercaptopurine, thioguanine, azathioprine)", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_ugt1a1_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "UGT1A1", "variant": "*1/*36", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Normal Metabolizer - normal processing of irinotecan, dolutegravir, raltegravir", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20240907_vkorc1_001", "document_hash": "f4ea737acc344938c03e24ce2d17c5b39c5147a39b30660cd03141b07444a5cb", "document_date": "2024-09-07", "category": "Genetic", "gene": "VKORC1", "variant": "Reference/Reference", "classification": "Pharmacogenomic", "inheritance": null, "condition": "Drug metabolism", "clinical_significance": "Indeterminate - affects warfarin sensitivity", "source_file": "/home/ai/clawd/repos/isaacstory2/Exams/Genetic/20240907_Variantyx_GeneticTest.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Exams/Genetic/20240907_Variantyx_GeneticTest.md"}
{"type": "variant", "id": "var_20210201_delecao_3q26_001", "document_hash": "f4996797581b95c3a841714ae3fa5a603fca619471551dbfebab6198db26903b", "document_date": "2021-02-01", "category": "Genetic", "gene": "3q26.31-26.32", "variant": "Deleção", "classification": null, "inheritance": null, "condition": null, "clinical_significance": "Deleção detectada no exoma", "source_file": "/home/ai/clawd/repos/isaacstory2/Prescriptions/Medications/20210701_DraSimone_Prescricao.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Prescriptions/Medications/20210701_DraSimone_Prescricao.md"}
{"type": "variant", "id": "var_20210114_mthfr_001", "document_hash": "0a6177dbbfbc924f2f2eb3b43ccd672e94e4b12bc517212bce4f8392f56b5875", "document_date": "2021-01-14", "category": "Genetic", "gene": "MTHFR", "variant": "1298C", "classification": null, "inheritance": "Heterozigoto", "condition": "Metabolismo do folato", "clinical_significance": "Dosar homocisteína anualmente, deve ficar abaixo de 10", "source_file": "/home/ai/clawd/repos/isaacstory2/Prescriptions/Medications/20210114_DraSimone_Prescricao.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Prescriptions/Medications/20210114_DraSimone_Prescricao.md"}
{"type": "variant", "id": "var_20230418_med13_001", "document_hash": "866209fe3ab7f68a4713fce6057f3b9ed72bb0f16cb2439126f07ccaaebb8f3b", "document_date": "2023-04-18", "category": "Genetic", "gene": "MED13", "variant": "VUS", "classification": "Variant of Unknown Significance (VUS)", "inheritance": null, "condition": "Neurodevelopmental disorders", "clinical_significance": "A genetic variant of unknown clinical significance was identified, associated with neurodevelopmental disorders", "source_file": "/home/ai/clawd/repos/isaacstory2/Consultations/20230712_MonicaCooke_Consulta.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Consultations/20230712_MonicaCooke_Consulta.md"}
{"type": "variant", "id": "var_20210109_mthfr_a1298c_001", "document_hash": "866209fe3ab7f68a4713fce6057f3b9ed72bb0f16cb2439126f07ccaaebb8f3b", "document_date": "2021-01-09", "category": "Genetic", "gene": "MTHFR", "variant": "A1298C", "classification": "Pathogenic", "inheritance": "Heterozygous", "condition": "Folate metabolism", "clinical_significance": "Affects folate processing; C677T normal", "source_file": "/home/ai/clawd/repos/isaacstory2/Consultations/20230712_MonicaCooke_Consulta.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Consultations/20230712_MonicaCooke_Consulta.md"}
{"type": "variant", "id": "var_20230418_med13_001", "document_hash": "701733b8205cd0014000fcbeed836f391e2cfb32974c4b5367db8f56b5a2167d", "document_date": "2023-04-18", "category": "Genetic", "gene": "MED13", "variant": null, "classification": "VUS", "inheritance": null, "condition": "Neurodevelopmental disorders", "clinical_significance": "Variant of unknown clinical significance associated with neurodevelopmental disorders", "lab": "TISMOO BIOTECH", "test_type": "Complete Exome Analysis", "sample_type": "Saliva", "source_file": "/home/ai/clawd/repos/isaacstory2/Consultations/20230901_MonicaCooke_Consulta.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Consultations/20230901_MonicaCooke_Consulta.md"}
{"type": "variant", "id": "var_20210109_mthfr_c677t_001", "document_hash": "701733b8205cd0014000fcbeed836f391e2cfb32974c4b5367db8f56b5a2167d", "document_date": "2021-01-09", "category": "Genetic", "gene": "MTHFR", "variant": "C677T", "classification": "Normal", "inheritance": "Homozygous wild-type", "condition": "Folate metabolism", "clinical_significance": "Normal variant - no impact on folate processing", "source_file": "/home/ai/clawd/repos/isaacstory2/Consultations/20230901_MonicaCooke_Consulta.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Consultations/20230901_MonicaCooke_Consulta.md"}
{"type": "variant", "id": "var_20210109_mthfr_a1298c_001", "document_hash": "701733b8205cd0014000fcbeed836f391e2cfb32974c4b5367db8f56b5a2167d", "document_date": "2021-01-09", "category": "Genetic", "gene": "MTHFR", "variant": "A1298C", "classification": "Heterozygous", "inheritance": "Heterozygous", "condition": "Folate metabolism", "clinical_significance": "Heterozygous carrier - may have mild impact on folate processing", "source_file": "/home/ai/clawd/repos/isaacstory2/Consultations/20230901_MonicaCooke_Consulta.pdf", "markdown_file": "/home/ai/clawd/repos/isaacstory2/markdown/Consultations/20230901_MonicaCooke_Consulta.md"}
